Evidence map›Paper›PMID 33516282›Full record

ArticleThe Lancet. Global health2021

SARS-CoV-2 testing for public health use: core principles and considerations for defined use settings.

Catharina Boehme, Emma Hannay, Rangarajan Sampath

Abstract read
In one paragraph

Article in The Lancet. Global health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Diagnostic accuracy of SARS-CoV-2 rapid antigen self-tests in asymptomatic individuals in the omicron period: a cross-sectional study.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Stroke Treatment in the Era of COVID-19: a Review.Current treatment options in neurology · 2022
    Review
  10. Article
  11. The potential of SARS-CoV-2 antigen-detection tests in the screening of asymptomatic persons.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2021
    Article
  12. SARS-CoV-2 rapid antigen detection tests.The Lancet. Infectious diseases · 2021
    Article
  13. Article
  14. Article
  15. Managing the risks of making the wrong diagnosis: First, do no harm.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Catharina BoehmeFoundation for Innovative New Diagnostics (FIND), Geneva 1202, Switzerland.
Emma HannayFoundation for Innovative New Diagnostics (FIND), Geneva 1202, Switzerland. Electronic address: emma.hannay@finddx.org.
Rangarajan SampathFoundation for Innovative New Diagnostics (FIND), Geneva 1202, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19COVID-19 TestingHumansSARS-CoV-2Travel

Identifiers

PMID33516282
PMCPMC7906635

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.